NOTV 3.21 (+15.05%)
US45783Q1004Medical Diagnostics & ResearchDiagnostics & Research

Inotiv (NOTV) Competitor Comparison

We are evaluating the key criteria listed to compare Inotiv (NOTV) against its competitors in the Diagnostics & Research industry.

Performance 10 years - NOTV ranking 27 / 58

These are the competitors of Inotiv in the industry Diagnostics & Research ranked by performance 10 years
1. Heska HSKA
1.65K
2. Lantheus Holdings LNTH
1.22K
3. Medpace Holdings MEDP
1K
4. RadNet RDNT
882.55
5. Natera NTRA
711.44
6. DexCom DXCM
475.28
7. IDEXX Laboratories IDXX
461.18
8. Thermo Fisher Scientific TMO
333.86
9. Danaher DHR
317.35
10. Mettler-Toledo MTD
307.27
11. Icon ICLR
261.22
12. PerkinElmer PKI
247.07
13. IQVIA Holdings IQV
246.73
14. NeoGenomics NEO
229.65
15. Waters WAT
219.08
16. Agilent Technologies A
205.68
17. Twist Bioscience TWST
199.69
18. Charles River Laboratories CRL
195.42
19. CareDx CDNA
194.4
20. Laboratory Corp of America Holdings LH
177.04
21. Quest Diagnostics DGX
156.99
22. Exact Sciences EXAS
120.67
23. Syneos Health SYNH
113.83
24. Fulgent Genetics FLGT
93.16
25. Qiagen QGEN
71.5
26. Meridian Bioscience VIVO
60.69
27. Inotiv NOTV
19.74
28. Ortho Clinical Diagnostics Holdings OCDX
13.74
29. Guardant Health GH
8.86
30. National Research NRC
5.8
31. Neogen NEOG
-11.38
32. Illumina ILMN
-22.12
33. Bioventus BVS
-26.29
34. Olink Holding OLK
-26.82
35. Anixa Biosciences ANIX
-40.38
36. Sotera Health SHC
-44.48
37. Myriad Genetics MYGN
-52.96
38. Sera Prognostics SERA
-57.1
39. Global Cord Blood CO
-66.57
40. Pacific Biosciences of California PACB
-73.2
41. DarioHealth DRIO
-75.47
42. Enzo Biochem ENZ
-76.73
43. MaxCyte MXCT
-79.75
44. Co-Diagnostics CODX
-81.67
45. Personalis PSNL
-81.78
46. Exagen XGN
-82.74
47. bioAffinity Technologies BIAF
-84.17
48. Psychemedics PMD
-84.52
49. MDxHealth MDXH
-85.6
50. Biodesix BDSX
-89.7
51. SeqLL SQL
-95.22
52. Prenetics Global PRE
-95.98
53. Neuronetics STIM
-97
54. Aspira Womens Health AWH
-97.44
55. Interpace Biosciences IDXG
-98.23
56. Trinity Biotech TRIB
-98.31
57. Organovo Holdings ONVO
-99.26
58. Precipio PRPO
-99.75

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.